PortfoliosLab logo

AVEO Pharmaceuticals, Inc. (AVEO)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in AVEO Pharmaceuticals, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,669 for a total return of roughly -83.31%. All prices are adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%100.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13Nov 20Nov 27Dec 04Dec 11Dec 18Dec 252023Jan 08Jan 15
92.28%
8.92%
AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AVEO

AVEO Pharmaceuticals, Inc.

Return

AVEO Pharmaceuticals, Inc. had a return of 0.33% year-to-date (YTD) and 302.14% in the last 12 months. Over the past 10 years, AVEO Pharmaceuticals, Inc. had an annualized return of -15.23%, while the S&P 500 had an annualized return of 10.37%, indicating that AVEO Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date0.33%3.47%
1 month0.54%3.95%
6 months116.14%-0.66%
1 year302.14%-12.36%
5 years (annualized)-12.54%7.17%
10 years (annualized)-15.23%10.37%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20229.15%12.99%1.73%79.47%1.22%0.00%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AVEO Pharmaceuticals, Inc. Sharpe ratio is 4.02. A Sharpe ratio of 3.0 or higher is considered excellent.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.004.00Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13Nov 20Nov 27Dec 04Dec 11Dec 18Dec 252023Jan 08Jan 15
4.02
-0.51
AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


AVEO Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13Nov 20Nov 27Dec 04Dec 11Dec 18Dec 252023Jan 08Jan 15
-92.78%
-17.18%
AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the AVEO Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AVEO Pharmaceuticals, Inc. is 98.75%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.75%Jul 22, 20112177Mar 18, 2020
-36.6%Apr 22, 201063Jul 21, 201046Sep 24, 2010109
-24.99%Nov 9, 2010100Apr 1, 201129May 13, 2011129
-14.31%Jun 3, 201111Jun 17, 20116Jun 27, 201117
-9%Oct 12, 201013Oct 28, 20105Nov 4, 201018
-7.26%Apr 13, 20101Apr 13, 20106Apr 21, 20107
-6.91%May 19, 20118May 31, 20112Jun 2, 201110
-5%Mar 16, 20108Mar 25, 20105Apr 1, 201013
-3.66%Jul 12, 20113Jul 14, 20115Jul 21, 20118
-2.52%Jun 30, 20112Jul 1, 20111Jul 5, 20113

Volatility Chart

Current AVEO Pharmaceuticals, Inc. volatility is 1.28%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13Nov 20Nov 27Dec 04Dec 11Dec 18Dec 252023Jan 08Jan 15
1.28%
16.43%
AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (^GSPC)